Hold at 200 SMA with 3-4 week Q3 binary catalyst; unfavorable asymmetry for new entries, maintain exposure with pre-committed stop
The asymmetric risk/reward (~3% upside to 50 SMA at $85.46 vs ~7-10% downside on 200 SMA break) is unfavorable for new entries at current levels. Both upgrade and downgrade scenarios have documented failure modes: the aggressive analyst's case matches the 9/21 Overweight call that produced alpha destruction, while full Underweight forecloses asymmetric upside given the ninth successful 200 SMA test since May and 9% buyback yield compounding. The Hold is differentiated from prior zero-alpha holds because the Q3 binary catalyst is now 3-4 weeks out, within the decision horizon. Price target is $85.00.
| Position | Action |
|---|---|
| Current position | Maintain current size; no full-conviction adds; no aggressive trims |
| Sidelined / no current position | Do not initiate at current levels — wait for technical setup to resolve (50 SMA reclaim on above-average volume OR post-Q3 drawdown holding $77-78 support with higher low) |
GM is deeply undervalued at $80.47 with a 12-month target of $95-105 (18-30% upside), as forward earnings recovery, record cash generation, and massive buybacks (33% share reduction in 3 years) are being ignored by a market anchored to a one-time Q4 2025 write-down.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | $80.41 | neutral |
| 50 SMA | $85.46 | bearish |
| 10 EMA | $82.57 | bearish |
| RSI | 40.90 | bearish |
| MACD | -1.10 | bearish |
| MACD Signal | -0.55 | bearish |
| MACD Histogram | -0.55 | bearish |
| ATR | $2.52 | neutral |
| Bollinger Middle (20 SMA) | $84.37 | bearish |
| Bollinger Lower Band | $79.93 | neutral |
| Bollinger Upper Band | $88.80 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Post-Q3 drawdown holding $77-78 support and printing a higher low
Then: Upgrade to Overweight
GM trades at a fraction of intrinsic value with forward earnings recovering sharply from Q4 2025's one-time charges.
EV: +18-30%
GM is a value trap at $80.47—the 200 SMA test is not a launchpad but the last support before a breakdown, as fundamentals are deteriorating (1.57% operating margins vs. 6-7% needed, 6.27% gross margins), the forward P/E is built on unrealistic ~571% EPS growth from $2.24 to ~$15.04, FCF conversion is abysmal at 0.96%, and macro headwinds (7.58% mortgage rates, 30Y yields at highest since 2002, 96% probability of zero 2026 Fed cuts) will compress GM Financial's $58B+ receivables book.
EV: -6% to -13%
→ vs conservative: Cherry-picked trailing 2-quarter FCF as negative (-$0.74B for Q1+Q2 2026) while ignoring Q2 2026 turned positive $1.10B and 2025 full-year positive $1.77B
→ vs conservative: Treats debt as universally bad; ignores that 5.5% borrowing cost vs 12% cost of equity makes debt-funded buybacks value-accretive
→ vs conservative: Anchoring on wrong resistance at 50 SMA (85.46) instead of prior highs at 90.11 and 91.85; upside is 14-15%, not 3%
→ vs conservative: Asymmetric risk/reward framing (3% upside vs 7-10% downside) is wrong on both ends; true downside is smaller given 200 SMA support defense
→ vs conservative: Treats $15 EPS estimate as gospel then dismisses setup; even materially below consensus the math still works
| neutral |
Support: 79.93 · 80.41 · 78 | Resistance: 82.57 · 85.46 · 88.8
GM is at a major decision point with price ($80.47) clinging to the 200 SMA at $80.41—a hairline-thin support that if broken could trigger a move toward $78. All shorter-term averages are above price (10 EMA $82.57, 50 SMA $85.46), and momentum indicators confirm bearish regime: MACD turned negative on 09-18 with histogram expanding to -0.55, while RSI has declined from 68.26 to 40.90 over two months. The September 18 distribution day (-5.1% on 21.1M shares) was the highest-volume day in the dataset, confirming the breakdown. The Bollinger lower band ($79.93) and 200 SMA form a critical confluence zone ($79.90–$80.50); a break below on volume >8M shares would be a sell signal. For longs, wait for a close above $82.57 with volume >7M and MACD histogram contraction for confirmation.
Market Capitalization
$72.78B
Beta
1.321
TTM P/E
35.92x
Forward P/E
5.35x
PEG Ratio
0.28
Price/Book
1.14x
Dividend Yield
0.89%
52-Week High
$91.85
52-Week Low
$54.33
50-Day Moving Average
$85.48
200-Day Moving Average
$80.72
Revenue 2025
$185.0B
Gross Profit 2025
$11.6B
Gross Margin 2025
6.27%
Operating Income 2025
$2.91B
Operating Margin 2025
1.57%
Net Income 2025
$2.70B
Diluted EPS 2025
$3.27
Diluted EPS TTM
$2.24
Diluted Shares Outstanding 2025
973M
Q2 2026 Revenue
$48.03B
Q2 2026 Operating Income
$1.46B
Q2 2026 Diluted EPS
$1.41
Q4 2025 Operating Income
($3.65B)
Q4 2025 Net Income
($3.31B)
Total Assets 2025
$281.3B
Total Debt 2025
$131.3B
Net Debt 2025
$109.3B
Stockholders' Equity 2025
$61.1B
Debt/Equity 2025
2.15x
Current Ratio 2025
1.17
Cash and ST Investments 2025
$27.67B
Operating Cash Flow 2025
$26.87B
CapEx Reported 2025
($9.30B)
CapEx Total Incl Financial 2025
($25.10B)
Free Cash Flow 2025
$1.77B
Share Buybacks 2025
($6.01B)
Dividends Paid 2025
($0.66B)
ROE 2025
3.16%
ROA 2025
2.25%
Profit Margin 2025
1.46%
FCF Margin 2025
0.96%
Equity Investment Losses 2025
$4.68B
Revenue 2022
$156.7B
Net Income 2022
$9.93B
Net Income 2023
$10.13B
Net Income 2024
$6.01B
Strengths
Concerns
GM presents a deeply cyclical recovery setup with weak 2025 results (net income $2.7B, operating margin 1.57%) driven by Q4'25 one-time charges of ~$3.6B operating loss, but Q1/Q2 2026 show strong recovery. The stock trades at a striking valuation divergence: TTM P/E of 35.92x reflects the depressed trailing earnings base versus a forward P/E of just 5.35x implying ~$15 EPS consensus recovery. Cash generation remains robust with record $26.87B operating cash flow and positive $1.77B FCF in 2025, while aggressive $6B+/year buybacks reduced share count by 33% since 2022. The analyst rates GM HOLD — the cheap forward valuation and capital return program are compelling but balanced by tariff uncertainty, cyclical risk, and the need for confirmed margin recovery before upgrading.
Macro: "Higher for longer" interest rate environment with 30-year Treasury yields at the highest level since 2002, mortgage rates at 7.58% near 3-year highs, and 96% Polymarket-implied probability of zero Fed cuts in 2026. Soft-landing base case dominates (8% recession probability). PBoC held rates September 30 with 100% certainty. Falling oil prices provide mild consumer discretionary offset. Gold at $4,147.70 signals risk-off macro anxiety.